To Pump or Not to Pump: A Comparison of Machine Perfusion vs Cold Storage for Deceased Donor Kidney Transplantation

Cannon et al. performed a retrospective analysis of the UNOS database from January 2005 to March of 2011, which included 52,052 kidney recipients.

They found that there was:

  • Significantly less DGF in both
    • Propensity matched cohort (21.1% MP vs 29.1% SCS)
    • Paired kidney cohort (19.7% MP vs 27.5% SCS)
  • For every 12.5 kidneys treated with MP, one episode of DGF is prevented relative to the CS group

They concluded that, given this evidence of reduced DGF, it might be advisable to substantially expand the use of MP beyond the current levels in the United States.

Read the full article here: https://doi.org/10.1016/j.jamcollsurg.2012.12.025

Tagged In:

DGF, HMP, Kidney

The Latest

Check out the most recent posts

Fox19—UC Health Performs First Cold Pump Liver Transplant

In this article from FOX19 NOW, meet the first liver transplant patient to receive a cold pump liver which was pumped on a LifePort® Liver Transporter during its clinical trial, PILOT™. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a...

ABC12 News—Organ Transplant Goes Hi-tech

In this article, Intermountain Healthcare takes part in the PILOT™ clinical trial of the LifePort® Liver Transporter. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a prospective randomized multi-center oxygenated hypothermic machine...

KSLTV—Doctors Testing New Liver Transplant Transport System

In this article, KSLTV of Salt Lake City reports on Intermountain Healthcare’s participation in the LifePort Liver Transporter clinical trial. “We’re keeping that liver working in a somewhat normal, physiologic state during the time that it’s out of the donor’s body...